Skip to main content
. 2021 Nov 16;13(22):5724. doi: 10.3390/cancers13225724

Figure 4.

Figure 4

Current TGF-β signaling inhibitors being used in combination with ICI for human clinical trials (adapted from “TGF-β signaling”, by BioRender.com (2021). Retrieved from https://app.biorender.com/biorender-templates, accessed on 14 October 2021).